Sale of Shares in Portage Biotech

Alpha Compute

28/06/2021 07:30

RNS Number : 2343D

FastForward Innovations Limited

28 June 2021

 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

 

28 June 2021

 

FastForward Innovations Ltd ("FastForward", "the Company" or, "FFWD")

 

Sale of Shares in Portage Biotech realising £396k profit

 

FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to announce the sale of a total of 18,183 ordinary shares in NASDAQ quoted Portage Biotech Inc. ("Portage") at an average price of approximately US$40.30 realising net proceeds of US$732,952 and representing a gain of approximately US$551,000 (£396,000 at today's exchange rate) (the "Sale") against the original cost price of the shares in FFWD's books of $10 per share. Following the Sale, FastForward remains interested in a total of 50,123 ordinary shares representing 0.4% of the issued share capital of Portage.

 

Based on the closing price on 25 June 2021, FastForward's remaining holding of 50,123 shares in Portage has a valuation of approximately US$1,265,600 (£911,000), compared to a valuation of $1,049,060 (£817,483) for the 104,906 shares held on the Company's most recent balance sheet at 30 September 2020 (at a 30 September 2020 market price of $10 per share).

 

Ed McDermott, CEO of FastForward Innovations, commented: "We are pleased to have realised part of our investment in Portage which has resulted in a return of some four times our original investment. This will provide us with further balance sheet resource enabling us to invest in other businesses that will bring value to shareholders."

 

 

 

For further information on the Company please visit www.fstfwd.co or contact:

Ed McDermott / Lance de Jersey
FastForward Innovations Ltd
Email: info@fstfwd.co
James Biddle / Roland Cornish
Beaumont Cornish Limited,
Nomad
Tel: +44 (0) 207 628 3396
Isabella Pierre / Damon Heath
Shard Capital Partners LLP
Tel: (0)207 186 9927
Isabel de Salis / Catherine Leftley/Charlotte Hollinshead
St Brides Partners Ltd,
Financial PR
Tel: +44 (0)207 236 1177

 

Notes

FastForward Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DISDKOBNNBKDDAB